Press Releases
View all press releases »
ION537 will be evaluated at MD Anderson in a Phase 1 study of patients with liver and head and neck cancers
ION537 will be evaluated at MD Anderson in a Phase 1 study of patients with liver and head and neck cancers
January 20, 2021 at 12:00 PM EST